DigiBiomics

PulmoDeep

Screening and diagnosis of lung infections and related diseases anomalies for early outbreak detection.

DigiBiomics is a pioneering Healthcare AI company, offering PulmoDeep, a cutting-edge tool for screening and early detection of lung diseases. Focused on predicting Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis through deep learning, PulmoDeep can be licensed to health authorities for visa screenings and proactive disease detection.

94%

Accuracy

94%

Long-term efficiency

83%

Cost-effective

Want to Chat? Feel free to Contact our Team.

If you have anything in mind just contact us with our expert.

Our Newsletter.

Get instant news by subscribe to our daily newsletter

Already subscribed? Unsubscribe